Similar articles

• Biomarkers of myocardial fibrosis.

  de Jong S, van Veen TA, de Bakker JM, Vos MA, van Rijen HV. de Jong S, et al. J Cardiovasc Pharmacol. 2011 May;57(5):522-35. doi: 10.1097/FJC.0b013e31821823d9. J Cardiovasc Pharmacol. 2011. PMID: 21423029 Review.
• Monitoring tissue repair and fibrosis from a distance.

  Weber KT. Weber KT. Circulation. 1997 Oct 21;96(8):2488-92. Circulation. 1997. PMID: 9355880 Review. No abstract available.
• Evidence for a causal role of oxidative stress in the myocardial complications of insulin resistance.

  Ritchie RH. Ritchie RH. Heart Lung Circ. 2009 Feb;18(1):11-8. doi: 10.1016/j.hlc.2008.11.003. Epub 2008 Dec 31. Heart Lung Circ. 2009. PMID: 19119069 Review. No abstract available.
• Peroxisome proliferator-activated receptor-gamma activation attenuates cardiac fibrosis in type 2 diabetic rats: the effect of rosiglitazone on myocardial expression of receptor for advanced glycation end products and of connective tissue growth factor.

  Ihm SH, Chang K, Kim HY, Baek SH, Youn HJ, Seung KB, Kim JH. Ihm SH, et al. Basic Res Cardiol. 2010 May;105(3):399-407. doi: 10.1007/s00395-009-0071-x. Epub 2009 Oct 23. Basic Res Cardiol. 2010. PMID: 19902320
• [Association between cardiac troponin I phosphorylation/degradation and cardiomyopathies].

  Zhu CX, Wu HF, Chen XJ. Zhu CX, et al. Zhonghua Xin Xue Guan Bing Za Zhi. 2007 Nov;35(11):996-9. Zhonghua Xin Xue Guan Bing Za Zhi. 2007. PMID: 18269818 Chinese.